Magnasense logotype

News

Brand Change Announcement: AegirBio AB has officially changed its name to Magnasense AB. The new website, www.magnasense.com, launched on 9 July 2024, with redirects from www.aegirbio.com.

Magnasense Technologies Oy and Salofa Oy Reach Settlement

Magnasense AB is pleased to announce that a settlement has been reached between Magnasense Technologies Oy and Salofa Oy. While the details of the agreement remain confidential, the Company is satisfied with the resolution and looks forward to focusing on future opportunities.

For additional information, please contact:
Marco Witteveen, CEO, Magnasense AB
Email: ir@magnasense.com
The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.se

About Magnasense AB
Magnasense is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, Magnasense was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Magnasense's website www.magnasense.com.

Attachments
Magnasense Technologies Oy and Salofa Oy Reach Settlement

All news Regulatory news Non-regulatory news regulatory